All News

A study found that cannabis use increased the risk of hospitalization and intensive care unit admission following a COVID-19 diagnosis.

Don’t miss out on the latest pharmacy insights in the Drug Topics June issue.

Check out these featured Drug Topics expert interviews from June 2024.

Drug Topics has been on site at McKesson ideaShare this week. Check out this podcast to hear a few of the exciting happenings at this year’s meeting.

The can’t-miss event on July 13 features speakers and CE sessions focused on streamlining pharmacy finances and services.

A study found that having a high level of melanoma knowledge was significantly correlated with having risk factors for the disease, such as skin ultraviolet radiation vulnerability and lighter hair color.

On the second anniversary of the overturning of Roe v Wade, check out recent coverage on abortion and contraceptive access.

Check out these top featured stories from Drug Topics in June 2024.

See what’s trending in pharmacy with a preview of the Total Pharmacy June issue.

Check out this recap of articles published on our sister sites during the past week.

Check out a recap of important pharmacy news you might have missed this week, dispensed in small doses.

The strongest independent predictors of becoming adherent to dermatology follow-up included younger age and prior outpatient visits.

Four abstracts presented at ASCO 2024 delved into cannabis and pain management, potential medication interactions, and symptom mitigation, in patients with cancer.

In a webinar conducted by the National Foundation for Infectious Diseases (NFID), experts gathered to publicly address the ongoing bird flu outbreak across many US states.

Check out important updates from the FDA for the week of June 17.

Patrick Alonso, PharmD, CPh, owner and manager of Your Tampa Health Care Advocates, talks about how to build trust with male patients, what health screenings men should be getting, and how pharmacists can help support men’s mental health.

Research presented at ASHP 2024 found that concerns around the safety of COVID-19 vaccines and the credibility of information from public health authorities were the biggest drivers of vaccine hesitancy during the COVID-19 pandemic.

For Migraine and Headache Awareness Month, Drug Topics spoke with Shivang Joshi, MD, MPH, RPh, FAHS to debunk migraine myths and explore resources to promote migraine awareness and education.

Shivang Joshi, MD, MPH, RPh, FAHS discusses how pharmacists can utilize their role as the most accessible health care professional to provide care to patients with migraine, as well as resources to enhance awareness and education.

A poster presented at AHS 2024 found that older patients tended to have more vitamin deficiencies compared to younger patients.

Cefepime/enmetazobactam was granted a 5-year exclusivity extension under GAIN Act legislation.

Shivang Joshi, MD, MPH, RPh, FAHS, headache specialist neurologist at Community Neuroscience Services, debunks common migraine myths.

Medication nonadherence can account for up to 50% of treatment failures and over $500 billion in annual health care costs.

In 2 abstracts presented at ASCO 2024, researchers addressed the use of GLP-1s for weight loss and to reduce cardiovascular outcomes in women with breast cancer.

A survey of health system specialty pharmacy employees found that hybrid work significantly improved quality of life and workplace productivity.

Struggling with gas, bloating, diarrhea, or other stomach issues? Don’t let digestive discomfort hold your patients back—check out these OTC products to get them feeling their best again.

Telepharmacy can empower pharmacists to practice at the top of their license, fostering a more efficient and accessible health care system that benefits both patients and providers.

A posted presented at ASHP 2024 examined if improved access to methadone could decrease hospital length of stay and readmission rates.